{"SPADE_UN_15819": {"Clinical Information": [], "Patent Information": [], "Sequence Information": {"SPADE ID": "SPADE_UN_15819", "Peptide Name": "LTV-HEXIM1 (147-164, LTV-BR", "Source": "Synthetic", "Family": "", "Gene": "Not found", "Sequence": "LTVSPWYGCGQLGKKKHRRRPSKKKRHW", "Sequence Length": 28, "UniProt Entry": ["http://www.uniprot.org/uniprot/O94992"], "Protein Existence": "Not found", "Biological Activity": ["Antimicrobial", "Anticancer"], "Target Organism": "Tumor cells:OPM-2 (30%Killing=50 µM)", "Hemolytic Activity": "Not available", "Cytotoxicity": "CHO-K1:0%Killing=50 µM; HFF:10%Killing=50 µM; WI-38:5%Killing=50 µM", "Binding Target": "Not available", "Linear/Cyclic": "Linear", "N-terminal Modification": "Free", "C-terminal Modification": "Free", "Stereochemistry": "L", "Structure Description": "Not found", "Formula": "C154H249N53O34S", "Mass": 3419.02, "PI": 11.62, "Net Charge": 12, "Hydrophobicity": -1.67, "Half Life": "Mammalian:5.5 hourYeast:3 minE.coli:2 min", "Literature": [{"Title": "Use of a novel cytotoxic HEXIM1 peptide in the directed breast cancer therapy", "Pubmed ID": "26734838", "Reference": "Oncotarget. 2016 Feb 2;7(5)5483-94.", "Author": "Neo SH, Lew QJ, Koh SM, Zheng L, Bi X, Chao SH.", "URL": "http://www.ncbi.nlm.nih.gov/pubmed/?term=26734838"}], "Frequent Amino Acids": "KRG", "Absent Amino Acids": "ADEFIMNOU", "Basic Residues": 12, "Acidic Residues": 0, "Hydrophobic Residues": 8, "Polar Residues": 19, "Positive Residues": 12, "Negative Residues": 0, "Similar Sequences": [{"SPADE_ID": "SPADE_UN_15815", "Similarity": 1.0, "Sequence": "QLGKKKHRRRPSKKKRHW"}, {"SPADE_ID": "SPADE_UN_15820", "Similarity": 0.7857142857142857, "Sequence": "LTVSPWYGCGQLGRRRHRRRPSRRRRHW"}, {"SPADE_ID": "SPADE_N_06613", "Similarity": 0.75, "Sequence": "KKKKRRKKWRKWLAKK"}]}}}